Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinalin vivostudy-Reference-Cited by-同舟云学术

Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinalin vivostudy

Published:2010-07-20 Issue:10 Volume:128 Page:2453-2462
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bäuerle Tobias,Komljenovic Dorde,Merz Maximilian,Berger Martin R.,Goodman Simon L.,Semmler Wolfhard

Funder

Deutsche Forschungsgemeinschaft

Merck-Serono

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.25563/fullpdf

Reference51 articles.

1. Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases;Guise;Genes Dev,2009

2. Integrin signaling revisited. Trends;Schwartz;Cell Biol,2001

3. The integrin alpha V beta 3: angiogenesis and apoptosis;Varner;Cell Adhes Commun,1995

4. Integrins: bidirectional, allosteric signaling machines;Hynes;Cell,2002

5. Immunohistochemical analysis of integrin alpha v beta3 expression on tumor-associated vessels of human carcinomas;Max;Int J Cancer,1997

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway;Journal of Cellular Physiology;2024-04

2. Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer;Life Sciences;2023-11

3. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma;Scientific Reports;2023-09-07

4. Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway;Heliyon;2023-07

5. Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential;Pathology - Research and Practice;2022-08